{
    "clinical_study": {
        "@rank": "62126", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Patients are given 5 pills (1 g per pill) of sodium chloride per day for 6 weeks. After a one-week wash out period, a second period of 6 weeks is started with 5 placebo (microcrystalline cellulose) pills per day."
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Patients are given 5 placebo (microcrystalline cellulose) pills per day for 6 weeks. After a one-week wash out period, a second period of 6 weeks is started with 5 pills (1 g per pill) of sodium chloride per day."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the present  study is to asses the effectiveness of the aorta-ventricular\n      coupling according to low and high sodium intake in 28 controled hypertensive patients."
        }, 
        "brief_title": "Influence of Sodium Intake on Left Ventricular-arterial Coupling", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "Comparison of left ventricular function in two groups of 13 patients according to their\n      different salt's consumption in double blind and crossover study.  Performance  estimation\n      of the left ventricle by echocardiographic and central arterial pressure by  tonometry."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Hypertension stage 1, with medium or high risk, when the treatment (mono or therapy\n             without diuretics) is efficient, when the great pressure is reached (<140/90 mmHg)\n\n          -  High sodium intake (sodium urinary excretion for 24h (UNaV) > or = 170 mmol/24h\n             before visit 0\n\n          -  Limited sodium intake objective (UNaV<85 mmol/24h)attempted at the end of the limited\n             sodium intake period of 2 weeks\n\n          -  Patients aged between 18 and 80 years\n\n          -  Subject has given written informed consent\n\n          -  Subject has subscribed a health care insurance\n\n        Exclusion Criteria:\n\n          -  Secondary hypertension\n\n          -  Complications associated with the arterial hypertension : history of cardiovascular\n             diseases or myocardial infarction, cerebrovascular accident, coronary disease, ...\n\n          -  Arterial hypertension associated with cardiopathy\n\n          -  Arterial hypertension associated with nephropathy\n\n          -  Arterial hypertension associated with diabetes\n\n          -  Measure of central arterial pressure by tonometry is impossible\n\n          -  Cardiac echogenicity is not satisfactory for the analysis of left ventricular loop\n             analysis\n\n          -  Patient refuses informed consent\n\n          -  Follow-up impossible for 15 weeks\n\n          -  Pregnant or women without efficacy contraception\n\n          -  Patient without freedom by administration decision\n\n          -  Patient in exclusion period\n\n          -  Patient without french insurance\n\n          -  Adult protected by the law"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01965236", 
            "org_study_id": "8985"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group 1", 
                    "Group 2"
                ], 
                "description": "Patients are given 5 pills (1 g per pill) of sodium chloride per day for 6 weeks. After a one-week wash out period, a second period of 6 weeks is started with 5 placebo (microcrystalline cellulose) pills per day.", 
                "intervention_name": "sodium chloride", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Group 1", 
                    "Group 2"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "hypertension, sodium intake, left ventricular function", 
        "lastchanged_date": "October 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34295"
                }, 
                "name": "Lapeyronie University Hospital of Montpellier"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Influence of Sodium Intake on Left Ventricular-arterial Coupling in Hypertension: Biomechanical Assessment and Modelisation of Left Ventricular Function With Arterial Pressure", 
        "overall_contact": {
            "email": "g-du_caylar@chu-montpellier.fr", 
            "last_name": "Guilhem DU CAYLAR, PhD", 
            "phone": "+33 4 67 33 84 43"
        }, 
        "overall_official": {
            "affiliation": "Department of intern Medicine and arterial Hypertension Lapeyronie University Hospital of Montpellier, Montpellier, France, 34295", 
            "last_name": "Guilhem DU CAYLAR", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "ultrasound volume, imaging \"strain\" and tonometry", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01965236"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}